Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aurora Cannabis (US) (TSE:ACB)
:ACB
Holding TSE:ACB?
Track your performance easily
ACB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$3.84 - C$12.85
Previous CloseN/A
Volume150.63K
Average Volume (3M)354.35K
Market Cap
C$326.52M
Enterprise ValueC$424.45M
Total Cash (Recent Filing)$174.64M
Total Debt (Recent Filing)$63.82M
Price to Earnings (P/E)―
Beta2.34
Next Earnings
Feb 06, 2025EPS Estimate
<0.01Last Dividend Ex-Date
Aug 23, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-0.86
Shares Outstanding54,877,160
10 Day Avg. Volume407,974
30 Day Avg. Volume354,353
Standard Deviation0.35
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.66
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit3.23
Enterprise Value/Ebitda75.44
Forecast
1Y Price Target
C$6.19Price Target Upside4.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Aurora Cannabis News
Options Prices
Currently, No data available
---
Ownership Overview
0.41% Insiders
0.09% Mutual Funds
<0.01% Other Institutional Investors
96.27% Public Companies and Individual Investors
ACB FAQ
What was Aurora Cannabis (US)’s price range in the past 12 months?
Aurora Cannabis (US) lowest stock price was C$3.84 and its highest was C$12.85 in the past 12 months.
What is Aurora Cannabis (US)’s market cap?
Aurora Cannabis (US)’s market cap is C$326.52M.
When is Aurora Cannabis (US)’s upcoming earnings report date?
Aurora Cannabis (US)’s upcoming earnings report date is Feb 06, 2025 which is in 22 days.
How were Aurora Cannabis (US)’s earnings last quarter?
Aurora Cannabis (US) released its earnings results on Nov 06, 2024. The company reported -C$0.22 earnings per share for the quarter, missing the consensus estimate of -C$0.108 by -C$0.112.
Is Aurora Cannabis (US) overvalued?
According to Wall Street analysts Aurora Cannabis (US)’s price is currently Undervalued.
Does Aurora Cannabis (US) pay dividends?
Aurora Cannabis (US) pays a Notavailable dividend of C$11.871 which represents an annual dividend yield of N/A. See more information on Aurora Cannabis (US) dividends here
What is Aurora Cannabis (US)’s EPS estimate?
Aurora Cannabis (US)’s EPS estimate is <0.01.
How many shares outstanding does Aurora Cannabis (US) have?
Aurora Cannabis (US) has 54,877,160 shares outstanding.
What happened to Aurora Cannabis (US)’s price movement after its last earnings report?
Aurora Cannabis (US) reported an EPS of -C$0.22 in its last earnings report, missing expectations of -C$0.108. Following the earnings report the stock price went down -15.957%.
Which hedge fund is a major shareholder of Aurora Cannabis (US)?
Among the largest hedge funds holding Aurora Cannabis (US)’s share is Gotham Asset Management LLC. It holds Aurora Cannabis (US)’s shares valued at 80K.
---
Aurora Cannabis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$6.19 (4.03% Upside)
C$6.19 (4.03% Upside)
Blogger Sentiment
Bullish
TSE:ACB Sentiment 70%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.02%
12-Months-Change
Fundamentals
Return on Equity
-12.38%
Trailing 12-Months
Asset Growth
-1.10%
Trailing 12-Months
Company Description
Aurora Cannabis (US)
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
---
ACB Company Deck
---
ACB Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was predominantly positive, with significant growth in global medical cannabis revenue, record adjusted EBITDA, and a strong balance sheet with no debt. Challenges included a decline in consumer cannabis revenue and seasonal fluctuations in plant propagation. Overall, the company's outlook remains optimistic with expectations of continued growth and positive cash flow.Read More>---
ACB Stock 12 Month Forecast
Average Price Target
C$6.19
▲(4.03% Upside)
Technical Analysis
Aurora Cannabis
―
Canopy Growth
―
Cronos Group
―
Tilray
―
OrganiGram Holdings
―
HLS Therapeutics Inc
―
Best Analysts Covering ACB
1 Year
1 Year Success Rate
7/18 ratings generated profit
1 Year Average Return
-7.32%
reiterated a buy rating 2 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 38.89% of your transactions generating a profit, with an average return of -7.32% per trade.
---